We use cookies for a better user experience. Read our Privacy Policy

I Agree

Polymerase Chain Reaction (PCR) Market

Polymerase Chain Reaction (PCR) Market (Product Type: Instruments, Reagents, and Consumables; and End-user: Pharmaceutical & Biotechnology Industries, Clinical Diagnostic Labs & Hospitals, Academic & Research Organizations, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Polymerase Chain Reaction (PCR) Market Outlook 2028

  • The global polymerase chain reaction (PCR) market was valued at US$ 4.1 Bn in 2020
  • It is estimated to expand at a CAGR of 6.4% from 2021 to 2028
  • The global polymerase chain reaction (PCR) market is expected to cross the value of US$ 8.1 Bn by the end of 2028

Analysts’ Viewpoint on Polymerase Chain Reaction (PCR) Market Scenario

Manufacturers in the PCR market are increasing the production for nose swab PCR tests for accurate and reliable testing for the COVID-19 virus. However, it has been found that the accuracy of RT-PCR results rely heavily on sample collection timing, type, storage, handling, and processing. The tests diagnose active infection only and cannot detect whether an individual was infected previously. A false negative result is possible if the sample is not properly obtained or if an individual is tested too early after the exposure to the virus or too late in their infection. Nevertheless, companies in the PCR market should boost output capacities for PCR tests due to the high prevalence of existing and potential infectious diseases.

PCR Gains Prominence in Ever-expanding Pharmaceutical and Biotechnology Industries

The polymerase chain reaction (PCR) approach has been demonstrated to be effective in pharmaceutical and biotechnology research, as well as in microbiological quality control. Additionally, the approach is used in genetic engineering. Genetic engineering is one of the primary drivers for the expansion of the global PCR market. PCR is being used to discover genes associated with specific phenotypes, such as genetic illnesses. The regular testing of raw materials and finished products for microbial contamination is a critical practice in pharmaceutical and biotechnology industries.

PCR is frequently used in critical processes for clinical laboratory research pertaining to various purposes, including biological research and criminal legal sciences. Polymerase chain reaction is a technique widely used to generate millions or billions of copies or duplicates or half-duplicates of a DNA, allowing researchers to take a small sample of DNA and intensify it (or a portion of it) to an enormous enough amount to concentrate exhaustively. Such findings are contributing toward growth of the PCR market.

Request a sample to get extensive insights into the Polymerase Chain Reaction (PCR) Market

Unprecedented Demand for RT-PCR Tests for COVID-19 Detection Creating Revenue Streams

The polymerase chain reaction test for COVID-19 is a molecular test that analyzes the upper respiratory specimen, looking for genetic material (ribonucleic acid or RNA) of SARS-CoV-2, the virus that causes COVID-19. Scientists are using the PCR technology to amplify small amounts of RNA from specimens into deoxyribonucleic acid (DNA), which is replicated until SARS-CoV-2 is detectable, if present. The PCR test has been emerging as the gold standard test for diagnosing COVID-19 since authorized for use in February 2020. Its accurate, convenient, and reliable outcome is being preferred by labs and research institutes.

To understand how our report can bring difference to your business strategy, Ask for a brochure

High Prevalence of Infectious Diseases in Asia Pacific to Expand Gobal Market

Molecular diagnosis has transformed modern diagnostic science, and polymerase chain reaction has emerged as the method of choice for the early & reliable detection of diseases. The expansion of top manufacturers of PCR products in Asia Pacific through network strengthening and new product launches in developing countries are key factors expected to drive the PCR market in the region during the forecast period.

Increase in incidence of cancer and infectious diseases has driven the demand for the use of polymerase chain reaction technique in clinical diagnosis of these diseases across Asia Pacific. The Korea Central Cancer Registry reported in 2016 that South Korea had 217,057 cancer cases in 2014. Such findings are fueling the growth of the Asia Pacific PCR market.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Polymerase Chain Reaction (PCR) Market

PCR Emerges as Alternative to Traditional Sputum Smear Microscopy Approach

Tuberculosis is one of the most widespread infectious illnesses, with a particularly high prevalence in developing nations. According to the World Health Organization (WHO), an estimated 10 million individuals were infected with tuberculosis globally in 2019. Thus, the PCR test has been recommended for quick detection of pulmonary tuberculosis, replacing the traditional sputum smear microscopy approach. China, India, and Indonesia were among the countries having a higher prevalence of the disease.

According to the World Health Organization (WHO), herpes simplex virus type 1 infects around 3.7 billion individuals worldwide. The rise in incidence of various infectious diseases is driving the demand for diagnostic products, which is expected to boost the growth of the PCR market.

Manufacturers Develop Comprehensive Product Portfolio for PCR Products

The introduction of advanced reagents specific to the type of test is expected to propel the global demand for PCR reagents in the near future. PCR reagents include template DNA, PCR primers & probes, dNTPs, PCR buffers, enzymes, and master mixes. PCR consumables mostly include PCR tubes, plates, and other accessories required to conduct PCR reactions.

Manufacturers in the PCR market are increasing production for standard PCR systems, RT PCR systems, and digital PCR systems. The revenue share of digital PCR systems is expected to grow at a rapid pace during the forecast period. This is attributable to advantages of digital PCR systems such as precision, sensitivity, accuracy, reproducibility, direct quantification & multiplexing, and speed of analysis.

Polymerase Chain Reaction (PCR) Market: Overview

  • Polymerase chain reaction (PCR) is a technique used to generate millions or billions of copies or duplicates or half-duplicates of a DNA, allowing researchers to take a small sample of DNA and intensify it (or a portion of it) to an enormous enough amount to concentrate exhaustively
  • It is used for genetic testing and research, including the examination of archaic DNA samples and the identification of irresistible specialists

Rise in R&D Expenditure: Key Driver

  • Increase in R&D expenditure, developments in pharmacogenomics, trend of self-diagnosis of diseases as a preventive measure, and emergence of the digital PCR technology highly benefiting cancer diagnosis are factors projected to boost the growth of the global PCR market during the forecast period
  • Moreover, rise in research & development activities in advanced molecular biology, genetic engineering, and forensic science are anticipated to propel the global PCR market during the forecast period

Rise in Prevalence of Tuberculosis and Other Infectious Diseases: Major Driver

  • Tuberculosis is one of the most widespread infectious illnesses, with a particularly high prevalence in developing nations
  • According to the World Health Organization (WHO), an estimated ten million individuals were infected with tuberculosis globally in 2019. Additionally, this PCR test has been recommended for quick detection of pulmonary tuberculosis, replacing the traditional sputum smear microscopy approach.
  • China, India, and Indonesia were among the countries having a higher prevalence of the disease
  • According to the World Health Organization (WHO), herpes simplex virus type 1 infects around 3.7 billion individuals worldwide. Increase in incidence of various infectious diseases drives demand for diagnostic products, which is expected to boost the growth of the global market.

Pharmaceutical & Biotechnology Segment to Dominate Global Polymerase Chain Reaction (PCR) Market

  • The polymerase chain reaction (PCR) approach has been demonstrated to be effective in pharmaceutical and biotechnology research, as well as microbiological quality control
  • Additionally, the approach is used in genetic engineering. Genetic engineering is the primary driver of the global polymerase chain reaction (PCR) market.
  • It is used to discover genes associated with specific phenotypes, such as genetic illnesses
  • Regular testing of raw materials and finished products for microbial contamination is a critical practice in the pharmaceutical and biotechnology industries
  • In the pharmaceutical industry, sophisticated analytical procedures such as polymerase chain reaction (PCR) have been frequently used for quality control analysis

North America to Dominate Global Polymerase Chain Reaction (PCR) Market

  • Increase in incidence of various types of cancer and metabolic diseases that demand advanced diagnosis and therapies are the major factors driving the market in North America
  • The advent of automated PCR instruments and higher purchasing power and affordability fuel the growth of the PCR market in developed countries in Europe such as the U.K., France, Italy, and Germany. Moreover, less stringent regulatory approval processes compared to the U.S. fuel the PCR market in Europe.
  • The market in Asia Pacific is projected to grow at a rapid pace during the forecast period, owing to improving health care infrastructure, rise in private and public investment in life science research, and technological advancements in countries such as China and India

Major Players

  • Key players operating in the global polymerase chain reaction (PCR) market include
    • Bio-Rad Laboratories, Inc.
    • QIAGEN N.V.
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific, Inc.
    • Becton
    • Dickinson and Company
    • Abbott
    • Siemens Healthcare GmbH (Siemens AG)
    • bioMérieux SA
    • Danaher Corporation
    • Agilent Technologies
  • Each of these players has been profiled in the polymerase chain reaction (PCR) market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Polymerase Chain Reaction (PCR) Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 4.1 Bn

Market Forecast Value in 2028

US$ 8.1 Bn

Growth Rate (CAGR)

6.4%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Product Type
  • Instruments
  • Standard PCR
  • RT PCR
  • Digital PCR
  • Reagents
  • Consumables
  • End-user
  • Pharmaceutical & Biotechnology Industries
  • Clinical Diagnostics Labs & Hospitals
  • Academic & Research Organizations
  • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Rest of the World

Customization Scope

Available upon request

Pricing

Available upon request

Polymerase Chain Reaction Market – Segmentation

TMR’s study on the global polymerase chain reaction market includes information divided into four segments: product type, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global polymerase chain reaction market are discussed in detail.

Product Type
  • Instruments
    • Standard PCR
    • RT PCR
    • Digital PCR
  • Reagents
  • Consumables
End-user
  • Pharmaceutical & Biotechnology Industries
  • Clinical Diagnostics Labs & Hospitals
  • Academic & Research Organizations
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
Polymerase Chain Reaction (PCR) Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of polymerase chain reaction (PCR) market?

Polymerase chain reaction (PCR) market is expected to cross the value of US$ 8.1 Bn by 2028

What is the anticipated CAGR of the polymerase chain reaction (PCR) market in the forecast period?

Polymerase chain reaction (PCR) market to expand at a CAGR of 6.4% from 2021 to 2028

What are the key driving factors for the growth of the polymerase chain reaction (PCR) market?

Polymerase chain reaction (PCR) market is driven by rise in prevalence of tuberculosis and other infectious diseases

Which region is expected to project the highest market share in the global polymerase chain reaction (PCR) market?

North America accounted for a major share of the global polymerase chain reaction (PCR) market

Who are the key players in the global polymerase chain reaction (PCR) market?

Key players in the global polymerase chain reaction (PCR) market include Bio-Rad Laboratories, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc. Becton

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global PCR Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

        4.3.4. Trends

    4.4. Global PCR Market Analysis and Forecast, 2017–2028

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Market Outlook

    5.1. Product Portfolio Analysis, by Key Players

    5.2. Distributor Analysis, by Key Players

    5.3. End-user Expectations from PCR Reagents & Instruments Manufacturers

    5.4. Market Value Share Analysis (%): by PCR Technology

    5.5. Clinical Diagnostic PCR Value Share (%) by Type of Diseases/Disorder

6. Global PCR Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2028

        6.3.1. Instruments

            6.3.1.1. Standard PCR Systems

            6.3.1.2. RT PCR Systems

            6.3.1.3. Digital PCR Systems

        6.3.2. Reagents

        6.3.3. Consumables

    6.4. Market Attractiveness Analysis, by Product

7. Global PCR Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by End-user, 2017–2028

        7.3.1. Pharmaceutical & Biotechnology Industries

        7.3.2. Clinical Diagnostics Labs & Hospitals

        7.3.3. Academic & Research Organizations

        7.3.4. Others

    7.4. Market Attractiveness Analysis, by End-user

8. Global PCR Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Rest of the World

    8.3. Market Attractiveness Analysis, by Country/Region

9. North America PCR Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Product, 2017–2028

        9.2.1. Instruments

            9.2.1.1. Standard PCR Systems

            9.2.1.2. RT PCR Systems

            9.2.1.3. Digital PCR Systems

        9.2.2. Reagents

        9.2.3. Consumables

    9.3. Market Value Forecast, by End-user, 2017–2028

        9.3.1. Pharmaceutical & Biotechnology Industries

        9.3.2. Clinical Diagnostics Labs & Hospitals

        9.3.3. Academic & Research Organizations

        9.3.4. Others

    9.4. Market Value Forecast, by Country, 2017–2028

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. by Product

        9.5.2. by End-user

        9.5.3. by Country

10. Europe PCR Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2017–2028

        10.2.1. Instruments

            10.2.1.1. Standard PCR Systems

            10.2.1.2. RT PCR Systems

            10.2.1.3. Digital PCR Systems

        10.2.2. Reagents

        10.2.3. Consumables

    10.3. Market Value Forecast, by End-user, 2017–2028

        10.3.1. Pharmaceutical & Biotechnology Industries

        10.3.2. Clinical Diagnostics Labs & Hospitals

        10.3.3. Academic & Research Organizations

        10.3.4. Others

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2028

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. by Product

        10.5.2. by End-user

        10.5.3. by Country/Sub-region

11. Asia Pacific PCR Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2028

        11.2.1. Instruments

            11.2.1.1. Standard PCR Systems

            11.2.1.2. RT PCR Systems

            11.2.1.3. Digital PCR Systems

        11.2.2. Reagents

        11.2.3. Consumables

    11.3. Market Value Forecast, by End-user, 2017–2028

        11.3.1. Pharmaceutical & Biotechnology Industries

        11.3.2. Clinical Diagnostics Labs & Hospitals

        11.3.3. Academic & Research Organizations

        11.3.4. Others

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2028

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. by Product

        11.5.2. by End-user

        11.5.3. by Country/Sub-region

12. Rest of the World PCR Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2028

        12.2.1. Instruments

            12.2.1.1. Standard PCR Systems

            12.2.1.2. RT PCR Systems

            12.2.1.3. Digital PCR Systems

        12.2.2. Reagents

        12.2.3. Consumables

    12.3. Market Value Forecast, by End-user, 2017–2028

        12.3.1. Pharmaceutical & Biotechnology Industries

        12.3.2. Clinical Diagnostics Labs & Hospitals

        12.3.3. Academic & Research Organizations

        12.3.4. Others

    12.4. Market Attractiveness Analysis

        12.4.1. by Product

        12.4.2. by End-user

13. Competition Landscape

    13.1. Market Player - Competition Matrix Competition Matrix (by tier and size of companies)

    13.2. Market Share Analysis by Company (2020)

    13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

        13.3.1. Bio-Rad Laboratories, Inc.

            13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.1.2. Product Portfolio

            13.3.1.3. SWOT Analysis

            13.3.1.4. Financial Overview

            13.3.1.5. Strategic Overview

        13.3.2. QIAGEN N.V.

            13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.2.2. Product Portfolio

            13.3.2.3. SWOT Analysis

            13.3.2.4. Financial Overview

            13.3.2.5. Strategic Overview

        13.3.3. F. Hoffmann-La Roche AG

            13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.3.2. Product Portfolio

            13.3.3.3. SWOT Analysis

            13.3.3.4. Financial Overview

            13.3.3.5. Strategic Overview

        13.3.4. Thermo Fisher Scientific, Inc.

            13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.4.2. Product Portfolio

            13.3.4.3. SWOT Analysis

            13.3.4.4. Financial Overview

            13.3.4.5. Strategic Overview

        13.3.5. Becton, Dickinson and Company

            13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.5.2. Product Portfolio

            13.3.5.3. SWOT Analysis

            13.3.5.4. Financial Overview

            13.3.5.5. Strategic Overview

        13.3.6. Abbott

            13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.6.2. Product Portfolio

            13.3.6.3. SWOT Analysis

            13.3.6.4. Financial Overview

            13.3.6.5. Strategic Overview

        13.3.7. Siemens Healthcare GmbH (Siemens AG)

            13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.7.2. Product Portfolio

            13.3.7.3. SWOT Analysis

            13.3.7.4. Financial Overview

            13.3.7.5. Strategic Overview

        13.3.8. BioMérieux SA

            13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.8.2. Product Portfolio

            13.3.8.3. SWOT Analysis

            13.3.8.4. Financial Overview

            13.3.8.5. Strategic Overview

        13.3.9. Danaher Corporation

            13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.9.2. Product Portfolio

            13.3.9.3. SWOT Analysis

            13.3.9.4. Financial Overview

            13.3.9.5. Strategic Overview

        13.3.10. Agilent Technologies

            13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.10.2. Product Portfolio

            13.3.10.3. SWOT Analysis

            13.3.10.4. Financial Overview

            13.3.10.5. Strategic Overview

List of Tables

Table 01: Global PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 02: Global PCR Market Size (US$ Mn) Forecast, by Instruments, 2017–2028

Table 03: Global PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 04: Global PCR Market Size (US$ Mn) Forecast, by Region, 2017–2028

Table 05: North America PCR Market Size (US$ Mn) Forecast, by Country, 2017–2028

Table 06: North America PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 07: North America PCR Market Size (US$ Mn) Forecast, by Instruments, 2017–2028

Table 08: North America PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 09: U.S. PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 10: U.S. PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 11: Canada PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 12: Canada PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 13: Europe PCR Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 14: Europe PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 15: Europe PCR Market Size (US$ Mn) Forecast, by Instruments, 2017–2028

Table 16: Europe PCR Market Size (US$ Mn) Forecast, by Industry, 2017–2028

Table 17: Germany PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 18: Germany PCR Market Size (US$ Mn) Forecast, of Industry, 2017–2028

Table 19: France PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 20: France PCR Market Size (US$ Mn) Forecast, Industry, 2017–2028

Table 21: Italy PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 22: Italy PCR Market Size (US$ Mn) Forecast, Industry, 2017–2028

Table 23: U.K. PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 24: U.K. PCR Market Size (US$ Mn) Forecast, Industry, 2017–2028

Table 25: Russia PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 26: Russia PCR Market Size (US$ Mn) Forecast, Industry, 2017–2028

Table 27: Spain PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 28: Spain PCR Market Size (US$ Mn) Forecast, Industry, 2017–2028

Table 29: Asia Pacific PCR Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 30: Asia Pacific PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 31: Asia Pacific PCR Market Size (US$ Mn) Forecast, by Instruments, 2017–2028

Table 32: Asia Pacific PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 33: China PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 34: China PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 35: India PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 36: India PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 37: Japan PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 39: Japan PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 40: Australia & New Zealand PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 41: Australia & New Zealand PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028

Table 42: Rest of the World PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028

Table 43: Rest of the World PCR Market Size (US$ Mn) Forecast, by Instruments, 2017–2028

Table 44: Rest of the World PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028

List of Figures

Figure 01: Global PCR Market Snapshot

Figure 02: Global PCR Market Size (US$ Mn) Forecast, 2017–2028

Figure 03: Market Value Share (%), by End-user (2017)

Figure 04: Market Value Share (%), by Region (2017)

Figure 05: Market Value Share (%), by Product (2017)

Figure 06: Global PCR Market Value Share (%), by Product, 2017 and 2028

Figure 07: Global PCR Market Attractiveness Analysis, by Product, 2021–2026

Figure 08: Global PCR Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Instruments Method, 2017–2028

Figure 09: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Reagents Method, 2017–2028

Figure 10: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Consumables Method, 2020–2028

Figure 11: Global PCR Market Value Share (%), by End-user, 2020 and 2028

Figure 12: Global PCR Market Value Share (%), by End-user, 2020 and 2028

Figure 13: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Pharmaceutical & Biotechnology Industries, 2020–2028

Figure 14: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinical Diagnostics Labs & Hospitals, 2020–2028

Figure 15: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Academic & Research Organizations, 2020–2028

Figure 16: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2020–2028

Figure 17: Global PCR Market Attractiveness Analysis, by Region, 2020–2028

Figure 18: Global PCR Market Value Share (%), by Region, 2017 and 2028

Figure 19: North America PCR Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028

Figure 20: North America PCR Market Value Share, by Country, 2020 and 2028

Figure 21: North America PCR Market Attractiveness Analysis, by Country, 2020–2028

Figure 22: North America PCR Market Value Share (%), by Product, 2020 and 2028

Figure 23: North America PCR Market Attractiveness Analysis, by Product, 2020–2028

Figure 24: North America PCR Market Value Share (%), by End-user, 2020 and 2028

Figure 25: North America PCR Market Attractiveness Analysis, by End-user, 2020–2028

Figure 26: Europe PCR Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028

Figure 27: Europe PCR Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

Figure 28: Europe PCR Market Attractiveness Analysis, by Country/Sub-region, 2020–2028

Figure 29: Europe PCR Market Value Share (%), by Product, 2020 and 2028

Figure 30: Europe PCR Market Attractiveness Analysis, by Product, 2018 and 2026

Figure 31: Europe PCR Market Value Share (%), by Industry, 2020 and 2028

Figure 32: Europe PCR Market Attractiveness Analysis, by Industry, 2018-2026

Figure 33: Asia Pacific PCR Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028

Figure 34: Asia Pacific PCR Market Value Share, by Country/Sub-region, 2020 and 2028

Figure 35: Asia Pacific PCR Market Attractiveness Analysis, by Country/Sub-region, 2020–2028

Figure 36: Asia Pacific PCR Market Value Share (%), by Product, 2020 and 2028

Figure 37: Asia Pacific PCR Market Attractiveness Analysis, by Product, 2020–2028

Figure 38: Asia Pacific PCR Market Value Share (%), by End-user, 2020 and 2028

Figure 39: Asia Pacific PCR Market Attractiveness Analysis, by End-user, 2020–2028

Figure 40: Rest of the World PCR Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028

Figure 41: Rest of the World PCR Market Value Share (%), by Product, 2020 and 2028

Figure 42: Rest of the World PCR Market Attractiveness Analysis, by Product, 2020–2028

Figure 43: Rest of the World PCR Market Value Share (%), by End-user, 2020 and 2028

Figure 44: Rest of the World PCR Market Attractiveness Analysis, by End-user, 2020–2028

Figure 45: Company Share Analysis (%), 2017 

Figure 46 Bio-Rad Laboratories, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2017–2020

Figure 47: Bio-Rad Laboratories, Inc. Breakdown of Net Sales, by Region, 2017

Figure 48: Bio-Rad Laboratories, Inc. Breakdown of Net Sales, by Business Segment, 2017

Figure 49: QIAGEN N.V. Breakdown of Net Sales, by Product Category, 2017

Figure 50: QIAGEN N.V. Revenue (US$ Mn) & Y-o-Y Growth (%), 2017–2020

Figure 51: QIAGEN N.V. Breakdown of Net Sales, by Region, 2017

Figure 52: F. Hoffmann-La Roche AG Revenue (US$ Bn) and Y-o-Y Growth (%), 2017–2020

Figure 53: F. Hoffmann-La Roche AG R&D Expenses, 2016–2017

Figure 54: F. Hoffmann-La Roche AG Breakdown of Net Sales, by Business Division, 2017

Figure 55: F. Hoffmann-La Roche AG Breakdown of Net Sales (Pharmaceutical Segment), by Region, 2017

Figure 56: Thermo Fisher Scientific, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2017–2020

Figure 57: Thermo Fisher Scientific, Inc. R&D Expenses, 2017–2020

Figure 58: Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Region, 2017

Figure 59: Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Business Segment, 2017

Figure 60: Becton, Dickinson and Company Revenue (US$ Bn) and Y-o-Y Growth (%), 2017–2020

Figure 61: Becton, Dickinson and Company R&D Intensity and Sales & Marketing Intensity – Company Level, (US$ Mn), 2016–2017

Figure 62: Becton, Dickinson and Company Breakdown of Net Sales, by Region, 2017

Figure 63: Becton, Dickinson and Company Breakdown of Net Sales, by Business Segment, 2017

Figure 64: Abbott Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2020

Figure 65: Abbott R&D Intensity and Sales & Marketing Intensity – Company Level, 2016–2017

Figure 66: Abbott Breakdown of Net Sales, by Segment, 2017

Figure 67: Abbott Breakdown of Net Sales (%), by Country, 2017

Figure 68: Siemens Healthcare GmbH Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017

Figure 69: Siemens Healthcare GmbH Diagnostics Segment R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017

Figure 70: Siemens Healthcare GmbH General and Administration Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017

Figure 71: Siemens Healthcare GmbH Diagnostics Business Segment, Breakdown of Net Sales (%), by Region, 2017

Figure 72: Siemens Healthcare GmbH Diagnostics Business Segment, Breakdown of Net Sales (%), by Business Segment, 2017

Figure 73: bioMérieux SA Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2020

Figure 74: bioMérieux SA R & D Expenses (US$ Bn), 2017–2020

Figure 75: bioMérieux SA Breakdown of Net Sales, by Region, 2017

Figure 76: bioMérieux SA Breakdown of Net Sales, by Segment, 2017

Figure 77: Danaher Corporation Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2020

Figure 78: Danaher Corporation R & D Expenses

Figure 79: Danaher Corporation Breakdown of Net Sales, by Region, 2017

Figure 80: Danaher Corporation Breakdown of Net Sales, by Segment, 2017

Figure 81: Agilent Technologies Breakdown of Net Sales, by Segment, 2017

Figure 82: Agilent Technologies Breakdown of Net Sales, by Region, 2017

Figure 83: Agilent Technologies Revenue (US$ Mn) & Y-o-Y Growth (%), 2017–2020

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

565

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved